chr19-45001656-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006509.4(RELB):c.77C>T(p.Pro26Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000315 in 1,522,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006509.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RELB | NM_006509.4 | c.77C>T | p.Pro26Leu | missense_variant | 1/12 | ENST00000221452.13 | |
RELB | NM_001411087.1 | c.77C>T | p.Pro26Leu | missense_variant | 1/11 | ||
RELB | XM_005259128.3 | c.77C>T | p.Pro26Leu | missense_variant | 1/11 | ||
RELB | XM_047439189.1 | c.-388C>T | 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RELB | ENST00000221452.13 | c.77C>T | p.Pro26Leu | missense_variant | 1/12 | 1 | NM_006509.4 | P2 | |
RELB | ENST00000505236.2 | c.77C>T | p.Pro26Leu | missense_variant | 1/11 | 5 | A2 | ||
RELB | ENST00000509480.5 | c.77C>T | p.Pro26Leu | missense_variant, NMD_transcript_variant | 1/5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000842 AC: 10AN: 118702Hom.: 0 AF XY: 0.0000765 AC XY: 5AN XY: 65348
GnomAD4 exome AF: 0.0000248 AC: 34AN: 1370468Hom.: 0 Cov.: 30 AF XY: 0.0000163 AC XY: 11AN XY: 675800
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74398
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.77C>T (p.P26L) alteration is located in exon 1 (coding exon 1) of the RELB gene. This alteration results from a C to T substitution at nucleotide position 77, causing the proline (P) at amino acid position 26 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 26 of the RELB protein (p.Pro26Leu). This variant is present in population databases (rs747010962, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with RELB-related conditions. ClinVar contains an entry for this variant (Variation ID: 1407890). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at